Skip to content

Soybean Based Diets and CVD Risk Factors

Impact of Different Forms of Soybean Based Foods on Cardiovascular Disease Risk Factors in Hypercholesterolemic Subjects.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00175097
Enrollment
30
Registered
2005-09-15
Start date
2001-06-30
Completion date
2005-05-31
Last updated
2014-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypercholesterolemia

Keywords

soy protein, lipids, lipoproteins, apolipoproteins, cholesterol, endothelial function

Brief summary

To evaluate the impact of soybean processing as well as the effect of soy relative to animal protein, independent of alterations in the fatty acid profile of the diet on CVD risk factors in hypercholesterolemic subjects.

Detailed description

Recent data suggests that the magnitude of the effect of soy protein on lipid and lipoprotein levels is variable and less dramatic than originally reported. This discordance might be attributable to the forms of soy protein used, as well as subtle unrecognized shifts in the fatty acid, cholesterol and fiber content of the diets.The aim of the present investigation is to assess the effects of different forms of soybeans (whole bean and products made thereof), products derived from soy flour (textured soy protein) and products made from a soybean extract (i.e. tofu, yogurt) relative to animal protein, independent of alterations in the fatty acid profile of the diet on CVD risk factors in hypercholesterolemic subjects. The intent is to isolate any potential impact of processing on the plasma lipid lowering efficacy of the soy product or soy protein relative to animal protein.

Interventions

OTHERDiet: soybeans and products made thereof

The macronutrient composition of each diets will be similar. The difference will be the type of protein (animal or soybean) or form of soybean incorporated into various food mixtures. This diet will incorporate soybeans and products made thereof.

OTHERDiet: soybean flour and products made thereof

The macronutrient composition of each diets will be similar. The difference will be the type of protein (animal or soybean) or form of soybean incorporated into various food mixtures. This diet will incorporate soybean flour and products made thereof.

OTHERDiet: soybean milk

The macronutrient composition of each diets will be similar. The difference will be the type of protein (animal or soybean) or form of soybean incorporated into various food mixtures. This diet will incorporate soybean milk.

OTHERDiet: Animal protein based diet

The macronutrient composition of each diets will be similar. The difference will be the type of protein (animal or soybean) or form of soybean incorporated into various food mixtures. This diet will incorporate animal protein.

Sponsors

Tufts University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Plasma LDL-C \>120mg/dL, Free from chronic illness, Not taking medications known to affect lipid metabolism (lipid lowering drugs, beta-blockers, fish-oil capsules, cis-retinoic acid, ascorbic acid, vitamin E, diuretics or hormones), Post-menopausal women.

Exclusion criteria

Soy allergy, Smokers, Consuming \>2 alcoholic drinks per day, Pre-menopausal women.

Design outcomes

Primary

MeasureTime frame
C-reactive protein; end of each dietary phase24 weeks
Fasting and non-fasting plasma lipids, apolipoproteins; end of each dietary phase24 weeks
Vascular endothelial function; end of each dietary phase24 weeks
Susceptibility of LDL to oxidation; end of each dietary phase24 weeks

Secondary

MeasureTime frame
Endogenous cholesterol synthesis; end of each dietary phase24 weeks
Endogenous triglyceride synthesis; end of each dietary phase24 weeks
Plasma and Urinary Isoflavone levels; end of each dietary phase24 weeks
Genotyping of candidate genes involved in the variability observed in response to dietary modification24 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026